Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

[1]  J. Sussman,et al.  New directions in the treatment of Gaucher disease. , 2004, Trends in pharmacological sciences.

[2]  G. Andria,et al.  The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement , 2003, Journal of Inherited Metabolic Disease.

[3]  R. Dwek,et al.  Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation. , 2003, The Biochemical journal.

[4]  P. Compain,et al.  Design, synthesis and biological evaluation of iminosugar-based glycosyltransferase inhibitors. , 2003, Current topics in medicinal chemistry.

[5]  R. Dwek,et al.  Therapeutic applications of imino sugars in lysosomal storage disorders. , 2003, Current topics in medicinal chemistry.

[6]  P. Compain,et al.  A general strategy for the practical synthesis of nojirimycin C-glycosides and analogues. Extension to the first reported example of an iminosugar 1-phosphonate. , 2002, The Journal of organic chemistry.

[7]  L. Pickering,et al.  Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins. , 2002, The Biochemical journal.

[8]  P. Compain,et al.  Carbohydrate mimetics-based glycosyltransferase inhibitors. , 2001, Bioorganic & medicinal chemistry.

[9]  D. Elstein,et al.  Gaucher's disease , 2001, The Lancet.

[10]  R. Dwek,et al.  Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders. , 2000, Chemical reviews.

[11]  R. Dwek,et al.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis , 2000, The Lancet.

[12]  R. Dwek,et al.  Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis , 2000 .

[13]  David A. Fletcher,et al.  The United Kingdom Chemical Database Service , 1996, J. Chem. Inf. Comput. Sci..

[14]  M. Horowitz,et al.  Mutations causing gaucher disease , 1994, Human mutation.

[15]  R. W. Brockman,et al.  Reactive 5'-substituted thymidine derivatives as potential inhibitors of nucleotide biosynthesis. , 1986, Journal of Medicinal Chemistry.

[16]  I. Pascher,et al.  Molecular arrangements in sphingolipids. The crystal structure of cerebroside , 1977 .